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Ketone bodies are produced by the liver and are used as an 
energy source when glucose is not available. The 2 main 
ketone bodies are acetoacetate and β-hydroxybutyrate 
(β-HB), while acetone is the least abundant ketone body.13 
Beta-hydroxybutyrate is derived from the reduction of ace-
toacetate in the mitochondria of the liver, and acetone is gen-
erated by spontaneous decarboxylation of acetoacetate. 
Patients suffering from diabetic ketoacidosis (DKA) display 
hyperglycemia, glucosuria, ketonuria, ketonemia, and meta-
bolic acidosis.9 The most popular method for the detection of 
ketone bodies is the urine dipstick method. Commercial 
ketone tests for urine are based on the Legal reaction, in which 
acetoacetate reacts with nitroprusside to produce a purple-
colored complex on the test strip. If glycine is added to the test 
reagent, the Legal reaction can also detect acetone. However, 
β-HB cannot be detected by using this method.13 Measurement 
of ketones in blood rather than in urine helps eliminate the 
risk of false negatives due to insensitivity and false positives 
due to drug interference.24 In urine samples, the nitroprusside 
reaction has been reported to give false-positive results in the 
presence of drugs containing sulfhydryl groups. False-negative 
readings have been reported when the test strips have been 
exposed to air for an extended time, after large intakes 
of vitamin C, or when bacteria in the urine metabolize 
acetoacetate.17 Moreover, the measurement of ketone bodies 
is influenced by renal function.8 Another difficulty is the sub-
jective evaluation of the color change of the urine stick. In 
human beings, the ketone body ratio in DKA is initially 3:1 
(β-HB:acetoacetate) and rises to as high as 10–20:1, leading 
to an underdiagnosis of hyperketonemia when testing for 
ketone bodies is performed by an urine stick only.10,15 During 
ketosis, β-HB levels increase more than levels of acetone and 
acetoacetate, making β-HB a more sensitive marker of keto-
sis.24 Moreover, β-HB is a more stable ketone body than ace-
tone or acetoacetate.14 In response to insulin therapy, β-HB 
levels commonly decrease long before acetoacetate levels.13 
In human medicine, quantitative measurement of capillary 
β-HB is performed routinely.4,11,12 In feline medicine, mea-
surement of β-HB using serum, plasma, or capillary blood 
has been described only in a few studies to date.5,22–24 The 
objectives of the current study were to assess the diagnostic 
utility of β-HB to diagnose diabetic ketosis (DK) and DKA, 
employing the hypothesis that cats with DKA have higher 
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Abstract. Diabetic ketoacidosis (DKA) is a life-threatening complication of diabetes mellitus (DM). The standard method 
of detection of ketone bodies is the dipstick method, which detects semiquantitatively acetoacetate, but not β-hydroxybutyrate 
(β-HB). The objectives of the current study were to assess the diagnostic utility of β-HB to diagnose diabetic ketosis (DK) and 
DKA in cats and to establish a cut-off value for the diagnosis of DKA. Sixty-two cats were included in the study. Eleven cats 
were healthy (group 1); in the remainder of cats (51), a diagnosis of DM was based on hyperglycemia, glucosuria, and increased 
fructosamine concentrations. Nineteen of 51 cats suffered from nonketotic diabetes mellitus (group 2). In 11 cats, plasma ketone 
bodies were detected with the dipstick method (diabetic ketosis, group 3). In 21 cats, plasma ketone bodies and metabolic 
acidosis were present (DKA, group 4). Plasma β-HB was measured in all cats by an enzymatic method (spectrophotometry). 
A cut-off value for the diagnosis of DKA was calculated based on the receiver operating characteristic curve. In healthy cats, 
the β-HB concentration ranged from 0 to 0.1 mmol/l; in cats of group 2, from 0 to 0.9 mmol/l (median: 0.1 mmol/l); in cats of 
group 3, from 0.6 to 6.8 mmol/l (median: 1.7 mmol/l); and in cats of group 4, from 3.8 to 12.2 mmol/l (median: 7.9 mmol/l). A 
cut-off value of 2.4 mmol/l revealed 100% sensitivity and 87% specificity to diagnose DKA. Beta-hydroxybutyrate is a useful 
parameter for the diagnosis of diabetic ketosis and DKA in cats.
Key words: Cats; ketone bodies; metabolic acidosis.
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β-HB concentrations compared to cats with DK, and to estab-
lish a cut-off value for the diagnosis of DKA.
Material and methods
Animals
Blood samples were collected from 11 healthy cats and from 
51 cats with diabetes mellitus (DM) presented to the Clinic 
of Small Animals, Faculty of Veterinary Medicine, Freie 
Universität (Berlin, Germany). All cats admitted to the hos-
pital between March 2009 and July 2010 with the diagnosis 
of DM were included in the study. Diabetes mellitus was 
diagnosed based on clinical signs, hyperglycemia in associa-
tion with glucosuria, and increased fructosamine concentra-
tions.9 Cats were excluded in cases of insufficient blood 
samples. In cats with DK and DKA but not in cats with non-
ketotic diabetes mellitus (NKD), plasma ketone bodies were 
also detected with the urine dipstick method. In addition to 
the detection of ketone bodies, cats with DKA were acidotic 
(HCO
3
- < 15 mmol/l; anion gap ≥ 25 mmol/l).9 Healthy cats 
that were presented for blood donation were used as controls, 
as they were considered healthy based on history and results 
of physical and laboratory examinations.
Blood collection and handling
Blood was collected from the cephalic, saphena, or external 
jugular vein by use of a 24-gauge needle and was placed in 
a heparinized tube.a Plasma was obtained by centrifugation 
(5 min at 8,000 × g).b The heparinized plasma was stored at 
–45°C for a maximum of 5 months until β-HB was deter-
mined. The study protocol was not approved by an animal use 
and care committee because cats provided samples as a part 
of their routine blood donor health check or as part of their 
diagnostic evaluation at the hospital. The rest of the plasma 
samples were used for the analysis of β-HB.
Beta-hydroxybutyrate measurement
Beta-hydroxybutyrate was measured by an enzymatic 
spectrophotometric methodc,d by an accredited veteri-
nary laboratory.e Beta-hydroxybutyrate, in the presence of 
hydroxybutyrate dehydrogenase, is oxidized to acetoacetate 
with the concomitant reduction of NAD+ to NADH. The 
NADH is re-oxidized to NAD+ by a redox mediator, which 
was directly proportional to the β-HB concentration. The 
coefficient of variation of the reference method was 3.7% 
between runs and 8.8% within runs.e
Blood gas analysis





, and lactate were measured in all cats 
within 15 min. The base excess and HCO
3
- concentrations 
were calculated in consideration of the the rectal temperature.g 
The chloride concentration was measured by an automatic 
analyzer.h The anion gap was calculated according to the 
following formula: (Na++ K+) – (Cl-+ HCO
3
-).7 Blood gas 
parameters, glucose, and lactate were measured with an auto-
mated analyzer using ion selective electrodes.g
Ketone body measurement by the dipstick method
Ketone bodies (acetoacetate, acetone) were semiquantitatively 
assessed in plasma by the use of urine dipsticks.i,24 According to 
the package insert, color changes of 1+, 2+, or 3+ correspond to 
concentrations of 1 mmol/l, 5 mmol/l, or 15 mmol/l, respec-
tively. A color change of (+) was interpreted as 0.5 mmol/l.
Statistical analysis
Descriptive statistics were used to report the results of the 
β-HB concentration, glucose, pH, HCO
3
-, base excess, lac-
tate, anion gap, and ketone bodies measured with the urine 
dipstick. SPSS 17 was used as statistical software.j A Mann–
Whitney test was performed to compare the β-HB concentra-
tions between the healthy cats and the cats with DM. Moreover, 
the values of DKA cats were compared to the values of the 
cats with DK. P-values ≤ 0.01 were considered significant. A 
receiver operating characteristic (ROC) curve was constructed 
from β-HB values measured with the reference method. 
Sensitivity and specificity were calculated with MedCalc sta-
tistical software.k The cut-off value for the diagnosis of 




Nineteen cats suffered from NKD (group 2), 11 from DK 
(group 3), and 21 from DKA (group 4). The results of the 
blood gas analysis, glucose, and ketone measurements are 
presented in Table 1.
Control group (group 1)
Nine of the cats were Domestic Shorthair cats, 1 was a 
Norwegian Forest Cat, and 1 a Maine Coon. The ages ranged 
from 2 to 11 years (median: 5 years). Two cats were female 
(both spayed), and 9 were males (8 neutered). The β-HB con-
centration in the 11 healthy cats ranged from 0 to 0.1 mmol/l 
(median: 0 mmol/l). The urine stick was negative for plasma 
ketone bodies in all cats in group 1.
Group 2 (nonketotic diabetes mellitus)
Group 2 was composed of Domestic Shorthair cats, and their 
ages ranged from 9 to 17 years (median: 14 years). Ten cats 
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were female (all spayed), and 9 cats were male (all neutered). 
Six of 19 cats had chronic renal failure, 2 cats had hypertro-
phic cardiomyopathy (HCMP), 3 cats had pancreatitis, and 
4 cats were diagnosed with pemphigus foliaceus, inflamma-
tory bowel disease, cat flu, and hyperthyroidism, respectively. 
In 4 cats, there was no concurrent disease present. Twelve cats 
were on insulin treatment. Cats with NKD had β-HB concen-
trations ranging from 0 to 0.9 mmol/l (median: 0.1 mmol/l). 
The dipstick method revealed no ketone bodies in plasma; 
however, in 8 cats, β-HB concentrations were increased (0.2–
0.9 mmol/l, median: 0.4 mmol/l) compared with healthy cats. 
One cat suffering from severe pancreatitis and thoracic effu-
sion died. This cat had a β-HB concentration of 0.5 mmol/l 
and an increased lactate concentration (5 mmol/l, pH 7.19).
Group 3 (diabetic ketosis)
Group 3 included 9 Domestic Shorthair cats, 1 British 
Shorthair, and 1 mixed-breed cat. The ages ranged from 7 to 
15 years (median: 12 years). Five cats were female (all 
spayed), and 6 cats were male (all neutered). In 5 cats with 
DK, the following additional diseases were detected: HCMP 
(n = 2), pancreatitis (n = 2), and cachexia with severe icterus 
(n = 1). Six of the 11 cats were already on insulin treatment. 
The cats in group 3 had β-HB values ranging from 0.6 and 
6.8 mmol/l (median: 1.7 mmol/l). All cats had ketone bodies 
in their plasma when tested by the urine stick ((+) to 3+, 
median: 1+). Seven cats with a dipstick reaction of (+) to 1+ 
had β-HB values ranging from 0.6 to 6.8 mmol/l (median: 
1.2 mmol/l). In 2 cats, the dipstick reaction was 2+ (β-HB: 
2.4 and 5.6 mmol/l) and 3+ (β-HB: 5.2 and 6.5 mmol/l), 
respectively. Nine cats survived. Two cats were euthanized 
for financial reasons.
Group 4 (diabetic ketoacidosis)
Group 4 was composed of 20 Domestic Shorthair cats and 
1 Chartreux. The ages ranged from 6 to 13 years (median: 
9 years). Six cats were female (all spayed), and 15 cats were 
male (all neutered). Sixteen of the 21 cats had additional 
diseases: pancreatitis (n = 8), HCMP (n = 3), hepatopathy 
(n = 2), atopy and glucocorticoid therapy (n = 1), and IBD, 
glucocorticoid therapy, and chronic renal failure (n = 1). 
Eight of the 21 cats were on insulin therapy at the time of 
presentation. The cats in group 4 had β-HB-concentrations 
ranging from 3.8 to 12.2 mmol/l (median: 7.9 mmol/l). In 
all 21 cats, plasma ketone bodies were also detected with 
the urine stick (1+ to 3+, median: 2+). Four cats had β-HB 
values ranging from 3.8 to 7.6 mmol/l (median: 6.2 mmol/l), 
and the dipstick reaction was weak (1+). In 11 cats with a 
dipstick reaction of 2+, the β-HB concentrations ranged 
from 4.2 to 12.2 mmol/l (median: 8 mmol/l). In 6 cats with 
dipstick reactions of 3+, the β-HB concentrations ranged 
from 4.9 to 10.4 mmol/l (median: 8.9 mmol/l). Ten cats of 
this group survived. Seven cats were euthanized as requested 
by their owners. Four cats died. These 4 cats had β-HB val-
ues of 5.7, 6.3, 6.7, and 6.8 mmol/l, respectively. The β-HB 
concentrations were significantly higher in DKA cats com-
pared to DK cats (P < 0.001).
Receiver operating characteristic analysis
All cats with DKA (group 4) had β-HB values ≥ 3.8 mmol/l. 
In 26 of 30 cats (86.7%) with NKD or DK, β-HB values were 
<2.4 mmol/l, the other 4 cats had values of 5.1, 5.2, 6.5, and 
6.8 mmol/l, respectively. An area under the curve of 0.97 was 
determined by ROC analysis (Fig. 1). At a cut-off value of 
2.4 mmol/l, the sensitivity and specificity was 100% and 
87%, respectively, for the diagnosis of DKA (Table 2).
Discussion
In human medicine, monitoring of ketone bodies is rec-
ommended in the guidelines of the American Diabetes 
Association and the International Diabetes Federation, and 
the determination of β-HB in blood is widely preferred over 
Table 1. Plasma glucose, pH, HCO
3
-, base excess, lactate, anion gap, β-hydroxybutyrate (β-HB) concentrations, and plasma ketone 
bodies (dipstick method) in 11 healthy cats and 51 cats with diabetes mellitus.
Control group (N = 11) Nonketotic diabetes mellitus (N = 19) Diabetic ketosis (N = 11) Ketoacidosis (N = 21)
Glucose (mmol/l)§ 5.3–8.5 (6.1) 5.5–35.2 (16.8) 17.9–27.7 (25.3) 13.6–42.1 (23.6)
pH 7.32–7.42 (7.38) 7.2–7.39 (7.32) 7.26–7.4 (7.35) 6.89–7.3 (7.13)
HCO
3
- (mmol/l) 18.8–22.9 (21.35) 15.7–30 (21) 15.1–26.9 (21.6) 5.8–22.6 (10.8)
Base excess (mmol/l) −6.3 to –1.9 (–3.8) −13–4.6 (–5.3) −11.2–0.2 (–4.8) −3.1 to –28.1 (18.6)
Lactate (mmol/l)§ 0.7–3.1 (1.2) 1.0–5.2 (3.2) 1.2–3.7 (2.3) 0.4–6.0 (1.7)
Anion gap (mmol/l) 18.2–19.9 (19.2) 14.8–29.6 (26.3) 11.1–24.9 (20.4) 25.3–47.6 (34.9)
β-HB (mmol/l) 0–0.1 (0) 0–0.9 (0.1) 0.6–6.8 (1.7)† 3.8–12.2 (7.9)‡
Urine dipstick (–/+) 0 (0) 0 (0) (+) to 3+ (1+) 1+ to 3+ (2+)
* Numbers in parentheses are median values.
† Significantly higher compared to healthy cats and cats with nonketotic diabetes mellitus (P ≤ 0.01).
‡ Significantly higher compared to cats with diabetic ketosis (P ≤ 0.01).
§ Not significantly different between the diabetic groups.
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Table 2. Criterion values and coordinates of the receiver 
operating characteristic curve.*
Criterion Sensitivity Specificity
≥0 100.00 (83.9–100.0) 0.00 (0.0–11.6)
>2.4† 100.00 (83.9–100.0) 86.67 (69.3–96.2)
>4.9 85.71 (63.7–97.0) 86.67 (69.3–96.2)
>5.2 85.71 (63.7–97.0) 93.33 (77.9–99.2)
>5.6 80.95 (58.1–94.6) 93.33 (77.9–99.2)
>6.5 76.19 (52.8–91.8) 96.67 (82.8–99.9)
>6.6 71.43 (47.8–88.7) 96.67 (82.8–99.9)
>6.8 66.67 (43.0–85.4) 100.00 (88.4–100.0)
>12.2 0.00 (0.0–16.1) 100.00 (88.4–100.0)
* Numbers in parentheses are 95% confidence intervals.
† Indicates the cut-off value.
urine testing.21 In feline medicine, the traditional measure-
ment of acetoacetate predominates, although determination 
of β-HB in blood has been published.5,22–24 Healthy cats have 
significantly lower β-HB concentrations compared to dia-
betic cats. Therefore, β-HB can be used as a marker for 
DM.23 In a study published in 2009,24 β-HB concentration 
was measured in the plasma of 54 cats with the hydroxybu-
tyrate esterase assay. Cats with NKD (n = 3) had β-HB con-
centrations of 0.02, 0.04, and 0.05 mmol/l, while those 
suffering from DK (n = 40) had concentrations between 0.06 
and 8.5 mmol/l (median: 0.72 mmol/l) and those suffering 
from DKA (n = 11) had β-HB values ranging from 6.5 to 
17.6 mmol/l (median: 11 mmol/l).24 The data of NKD and 
DK cats were similar compared to the results of the current 
study. However, the β-HB values of the cats with DKA were 
higher, which may be explained by differences in the assay.
The plasma samples in the present study were stored for 
up to 5 months at –45°C. The influence of storage was not 
evaluated. Human EDTA plasma samples were stored at 
room temperature, 4°C, –17°C, and –80°C. Within 21 days, 
a significant decrease in β-HB was detected after storage at 
room temperature or at 4°C, but not at –17°C or below.14 To 
the authors’ knowledge, data from veterinary medicine are 
not available.
The results of the present study revealed that the determi-
nation of urine ketone bodies using only the nitroprusside 
reaction can underestimate the number of cats with ketosis. 
In 8 cats with a β-HB concentration of 0.2–0.9 mmol/l, the 
dipstick reaction was negative. The dipstick reaction was 
lower in 5 (1+/β-HB: 5.1–7.6 mmol/l; 2+/β-HB: 12 mmol/l) 
and higher in 3 (3+/β-HB: 4.9-6.5 mmol/l) cats compared to 
the β-HB concentration. The quantitative measurement of β-
HB is more useful for follow-ups of cats with DK or DKA 
compared to the dipstick method.
Similar to human patients, β-HB may be the predominant 
ketone body in cats, and the measurement of β-HB is an 
important parameter for the diagnosis of ketonemia. In 
human medicine, treatment guidelines based on the level of 
β-HB concentration exist.6,12,18–20 Beta-hydroxybutyrate lev-
els do not normally exceed 1 mmol/l in patients who have no 
evidence of metabolic decompensation, regardless of the 
prevailing glucose concentration. Human beings with β-HB 
levels higher than 3 mmol/l are at risk of DKA, and immedi-
ate medical advice is recommended.19 In another human 
study, a cut-off value of 3 mmol/l revealed 100% sensitivity 
and 88% specificity to diagnose DKA.12 In human medicine, 
the change in β-HB during treatment of DKA is also inter-
preted. Optimal treatment would reduce β-HB by 1 mmol/l 
per hour; failure to do so suggests inadequate treatment.20
In the present study, a cut-off value of 2.4 mmol/l revealed 
100% sensitivity and 87% specificity for the diagnosis of 
DKA in cats, which is similar to the cut-off value in human 
beings. This cut-off value led to false-positive results in 13% 
of the cases and to no false-negative results. This means that 
in 4 cats, DKA was suspected when only DK was present. 
The suspicion of DKA would lead to a more intensive moni-
toring and treatment, which is not harmful for the cat. In the 
case of a false-negative result, however, a life-threatening 
situation may be missed. In cats with a β-HB concentration 
< 2.4 mmol/l, DKA is very unlikely.
In 4 out of 30 cats with DK, β-HB values were higher than 
2.4 mmol/l. One of these cats suffered from severe HCMP, 
2 cats from acute pancreatitis, and the fourth cat was cachectic 
and severely icteric. An increased catabolism due to diseases 
such as pancreatitis, hepatic lipidosis, or other metabolic dis-
turbances might have caused increased concentrations of 
β-HB in these 4 cats, even though there was no acidosis pres-
ent (Aroch I, Shechter M, Segev G: 2009, A retrospective 
case-controlled study of serum betahydroxybutyric acid in 
Figure 1. Receiver operating characteristic curve depicting 
the diagnostic value of the spectrophotometric method to detect 
increased β-hydroxybutyrate concentrations in cats. The area under 
the curve is 0.97.
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215 ill cats: clinical and clinical-pathological findings, diag-
nosis, morbidity and mortality. Proceeding of the 19th 
Annual European College of Veterinary Internal Medicine 
Congress, September 10–12, Porto, Portugal). In a prospec-
tive study, it was shown that the β-HB concentration 
increased (up to 1.57 mmol/l) in 8 obese cats after a fasting 
period of 5–6 weeks.1 Moreover, the elimination of ketone 
bodies is regulated by renal function and may be increased in 
cases of renal failure.2,6 However, none of these 4 cats was 
azotemic. Another cat in group 2 (NKD) had metabolic aci-
dosis (pH 7.19), but a negative dipstick test. This cat had 
lactic acidosis and was classified as NKD, although the 
β-HB concentration was 0.5 mmol/l.
Limitations of the current study are the criteria to define 
DKA. Although DKA is normally defined as a triad com-
posed of hyperglycemia, acidosis, and ketosis, specific val-
ues for glucose, bicarbonate, and blood pH vary in the 
veterinary literature.16 This lack of standardization could 
have contributed to the overlap in β-HB concentrations 
among the groups. Furthermore, cats with DKA frequently 
are presented with conditions such as protracted vomiting, 
diarrhea, and dehydration that may cause mixed acid-base 
disturbances. In human medicine, it is assumed that anion 
gap, HCO
3
-, and pH are relatively nonspecific for DKA 
because they can be affected by the degree of respiratory 
compensation or the presence of a separate acid disturbance. 
Ketone body production on the other hand is accompanied 
by equimolar production of hydrogen ions.18 Another limi-
tation of the study is the usage of venous blood samples for 
the determination of the acid-base status. Technical difficul-
ties in drawing arterial blood samples from cats were the 
cause for this approach. A study in human medicine, how-
ever, concluded that venous blood gas measurements accu-
rately demonstrate the degree of acidosis of patients with 
DKA.3
Blood ketone testing methods that quantify β-HB are not 
immediately available for every practitioner. The measure-
ment of β-HB in an external laboratory is time-consuming. 
Portable devices used in human medicine can also be used 
in veterinary medicine.22 In a previous study, it was shown 
that in cats a portable ketone meterl was accurate for the 
quantitative measurement of β-HB concentrations <4 mmol/l.22 
Values higher than 4 mmol/l β-HB concentrations were 
underestimated. However, data from the portable ketone 
meter tested cannot be extrapolated to other instruments; 
each portable device has to be evaluated individually.
The measurement of β-HB is a useful parameter for the 
diagnosis of DKA. A cut-off value of 2.4 mmol/l revealed 
100% sensitivity and 87% specificity to diagnose DKA. If a 
blood gas analysis cannot be performed, measuring the β-HB 
concentration allows for a diagnosis of DKA if β-HB con-
centrations are beyond the cut-off value. But it is important 
to note that there is no single test that can be used for a diag-
nosis of DKA on its own.
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